Diet-related Improvement of Non-Alcoholic Fatty Liver Based on Iranian Traditional Medicine (Persian Medicine): Case Report

Document Type : Case reports or series


1 Department of Traditional Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

2 Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Baqiatallah Research Center for Gastroenterology and liver disease, Baqiatallah University of Medical Science, Tehran, Iran


Background: NAFLD is the most common cause of chronic liver disease worldwide. The recommended therapy is lifestyle modification, which consists of dietary interventions and physical activity. The first line of treatment in Iranian Traditional Medicine (ITM) regardless of the type of disease is following the six essential principles named Setteh-ye- zarourieh, of which diet is the most important. The long process of treating NAFLD requires a comprehensive lifestyle design, which can be suited for the patients.
Case Presentation: A 57-year-old woman is a known case of NAFLD (grade II-III) accompanied by Insulin resistance, obesity and abnormal liver function tests (LFT). The accompanied sign and symptoms were heartburn, taste of acid, constipation and moderate weakness. The quality of life assessment was performed with SF-36 questionnaire.
Intervention: The patient underwent three months of dietary treatment based on Iranian Traditional Medicine (ITM).
Conclusion: Insulin resistance, obesity and LFT levels improved completely in 3 months and grading of fatty liver decreased to I-II. Afterwards the liver improved entirely and remains healthy after 2 years.


[1] Salomone F, Godos J, Zelber-Sagi S. Natural antioxidants for non-alcoholic fatty liver disease: Molecular targets and clinical perspectives. Liver Int 2015:5–20. doi:10.1111/liv.12975.
[2] Eslamparast T, Eghtesad S, Poustchi H, Hekmatdoost A. Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease. World J Hepatol 2015;7:204–12. doi:10.4254/wjh.v7.i2.204.
[3] Zivkovic AM, German JB, Sanyal AJ. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr 2007;86:285–300. doi:86/2/285 [pii].
[4] George ES, Forsyth A, Itsiopoulos C, Nicoll AJ, Ryan M, Sood S, et al. Practical Dietary Recommendations for the Prevention and Management of Nonalcoholic Fatty Liver Disease in Adults. Adv Nutr 2018;9:30–40.
[5] Moghaddasifar I, Lankarani KB, Moosazadeh M, Afshari M, Ghaemi A, Aliramezany M, et al. Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran. Int J Organ Transplant Med 2016;7:149.
[6] Askari F, Rashidkhani B, Hekmatdoost A. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients. Nutr Res 2014;34:143–8. doi:10.1016/j.nutres.2013.11.005.
[7] Tajadini H, Choopani R, Saifadini R. Lifestyle Methods for Prevention of Alzheimer’s Disease From the Perspective of Traditional Persian Medicine. J Evid Based Complement Altern Med 2015:1–3. doi:10.1186/s12889-015-2428-4r10.1177/2156587215611787.
[8] Tonekaboni MM. Tohfat al-Momenin. Qom: Noor e vahi; 2011.
[9] Xue Z, Gao J, Zhang Z, Yu W, Wang H, Kou X. Antihyperlipidemic and Antitumor Effects of Chickpea Albumin Hydrolysate. Plant Foods Hum Nutr 2012;67:393–400. doi:10.1007/s11130-012-0311-3.
[10] Yang Y, Zhou L, Gu Y, Zhang Y, Tang J, Li F, et al. Dietary chickpeas reverse visceral adiposity, dyslipidaemia and insulin resistance in rats induced by a chronic high-fat diet. Br J Nutr 2007;98:720–6. doi:10.1017/S0007114507750870.
[11] Shivashri C, Rajarajeshwari T, Rajasekar P. Hepatoprotective action of celery (Apium graveolens) leaves in acetaminophen-fed freshwater fish (Pangasius sutchi). Fish Physiol Biochem 2013;39:1057–69. doi:10.1007/s10695-012-9762-6.
[12] Li P, Jia J, Zhang D, Xie J, Xu X, Wei D. In vitro and in vivo antioxidant activities of a flavonoid isolated from celery (Apium graveolens L. var. dulce). Food Funct 2013:24232123. doi:10.1039/c3fo60273g.
[13] Bolling BW, Chen C-YO, McKay DL, Blumberg JB. Tree nut phytochemicals: composition, antioxidant capacity, bioactivity, impact factors. A systematic review of almonds, Brazils, cashews, hazelnuts, macadamias, pecans, pine nuts, pistachios and walnuts. Nutr Res Rev 2011;24:244–75. doi:10.1017/S095442241100014X.
[14] Zarshenas MM, Farrokhi RR, Akhavein M, Kiafar MR. A panoramic view of chronic liver diseases and natural remedies reported in Traditional Persian Medicine. Curr Pharm Des 2015:350–64.
[15] Khorasani MHA. Makhzan al-Adwiah. Tehran: Tehran University of Medical Science; 2011.
[16] Dolas Ashadevi S, Gotmare SR. THE HEALTH BENEFITS AND RISKS OF ANTIOXIDANTS. Pharmacophore 2015;6.
[17] Khoubnasabjafari M, Jouyban A. A review of phytochemistry and bioactivity of quince (Cydonia oblonga Mill.). JMedPlants Res 2011;5:3577–94.
[18] Boyer J, Liu RH. Apple phytochemicals and their health benefits. Nutr J 2004;3:5. doi:10.1186/1475-2891-3-5.
[19] Sina HIAI. Al-Qanun fi’l-Tibb. Alamy Le-Al- Matbooat institute; 2005.
[20] G KM, Pallavi E, B RK, Ramesh M, Venkatesh S. Hepatoprotective activity of Ficus carica Linn . leaf extract against carbon tetrachloride-induced hepatotoxicity in rats. DARU J Pharm Sci 2007;15:162–6.
[21] Solomon A, Golubowicz S, Yablowicz Z, Grossman S, Bergman M, Gottlieb HE, et al. Antioxidant activities and anthocyanin content of fresh fruits of common fig (Ficus carica L.). J Agric Food Chem 2006;54:7717–23.
[22] Javadi B, Sahebkar A, Emami SA. A survey on saffron in major Islamic traditional medicine books. Iran J Basic Med Sci 2013;16:1–11.
[23] Hosseinzadeh H, Nassiri-Asl M. Avicenna’s (Ibn Sina) the canon of medicine and saffron (Crocus sativus): A review. Phyther Res 2013;27:475–83. doi:10.1002/ptr.4784.
[24] Amin A, Hamza AA, Bajbouj K, Ashraf SS, Daoud S. Saffron: a potential candidate for a novel anticancer drug against hepatocellular carcinoma. Hepatology 2011;54:857–67.
[25] Dongiovanni P, Lanti C, Riso P, Valenti L. Nutritional therapy for nonalcoholic fatty liver disease. J Nutr Biochem 2016;29:1–11. doi:10.1016/j.jnutbio.2015.08.024.
[26] Ko S-H, Park J-H, Kim S-Y, Lee SW, Chun S-S, Park E. Antioxidant effects of spinach (Spinacia oleracea L.) supplementation in hyperlipidemic rats. Prev Nutr Food Sci 2014;19:19–26.
[27] Panahi Y, Kianpour P, Mohtashami R, Jafari R, Simental-Mendía LE, Sahebkar A. Curcumin lowers serum lipids and uric acid in subjects with nonalcoholic fatty liver disease: a randomized controlled trial. J Cardiovasc Pharmacol 2016;68:223–9.
[28] Verma S, Thuluvath PJ. Complementary and Alternative Medicine in Hepatology: Review of the Evidence of Efficacy. Clin Gastroenterol Hepatol 2007;5:408–16. doi:10.1016/j.cgh.2006.10.014.
[29] Moneim AEA, Dkhil MA, Al-quraishy S. Studies on the effect of pomegranate ( Punica granatum ) juice and peel on liver and kidney in adult male rats 2011;5:5083–8.
[30] Al-Muammar MN, Khan F. Obesity: The preventive role of the pomegranate (Punica granatum). Nutrition 2012;28:595–604. doi:10.1016/j.nut.2011.11.013.
[31] Al-Okbi SY, Mohamed D a., Hamed TE, Esmail RSH. Rice Bran Oil and Pumpkin Seed Oil Alleviate Oxidative Injury and Fatty Liver in Rats Fed High Fructose Diet. Polish J Food Nutr Sci 2014;64:127–33. doi:10.2478/pjfns-2013-0002.
[32] Himesh S, Nanda S, Singhai AK, Jitender M. Radical scavenging activities and natural indicator activity of Aqueous and ethanolic extract of Rosa damascena. Int J Pharm Pharm Sci 2012;4:581–6.
[33] Anderson R a. Cinnamon and Glucose Homeostasis. Nutr Today 2014;49:S10–1. doi:10.1097/01.NT.0000453897.82177.40.
[34] Hasani-Ranjbar S, Larijani B, Abdollahi M. A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflamm Allergy Drug Targets 2009;8:2–10. doi:10.2174/187152809787582561.
[35] Zl L, Lz X, Zhu J, Gq L, Sj G, Jp L. Herbal medicines for fatty liver diseases ( Review ). Cochrane Collab 2013.
[36] Khan S, Shah AS, Rahim H, Gillani FM, Chisti KA, Shah M, et al. Effect of Nigella Sativa Tablets on Various Parameters of Insulin Resistance Syndrome in Fatty Liver Disease at Peshawar Cantonment Govt Lady Reading Teaching Hospital Peshawar , Khyber Pakhtunkhwa , Pakistan. Am J Toxicol Sci 2015;7:243–6. doi:10.5829/idosi.aejts.2015.7.4.95227.
[37] Asadi-Samani M, Kafash-Farkhad N, Azimi N, Fasihi A, Alinia-Ahandani E, Rafieian-Kopaei M. Medicinal plants with hepatoprotective activity in Iranian folk medicine. Asian Pac J Trop Biomed 2015;5:146–57. doi:10.1016/S2221-1691(15)30159-3.
[38] Baselga-Escudero L, Souza-Mello V, Pascual-Serrano A, Rachid T, Voci A, Demori I, et al. Beneficial effects of the Mediterranean spices and aromas on non-alcoholic fatty liver disease. Trends Food Sci Technol 2017.
[39] Avery L, Exley C, McPherson S, Trenell MI, Anstee QM, Hallsworth K. Lifestyle behaviour change in patients with non-alcoholic fatty liver disease: A qualitative study of clinical practice. Clin Gastroenterol Hepatol 2017.
[40] Conlon BA, Beasley JM, Aebersold K, Jhangiani SS, Wylie-Rosett J. Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). Nutrients 2013;5:4093–114. doi:10.3390/nu5104093.
[41] Corrado RL, Torres DM, Harrison S a. Review of treatment options for nonalcoholic Fatty liver disease. Med Clin North Am 2014;98:55–72. doi:10.1016/j.mcna.2013.09.001.
[42] Kani AH, Alavian SM, Esmaillzadeh A, Adibi P, Azadbakht L. Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial. Nutrition 2014;30:814–21. doi:10.1016/j.nut.2013.11.008.